INDIA – Apollo Hospitals has teamed up with Imperial Hospital to strengthen its presence in Bangladesh to enable access to world-class treatments.
Apollo hospitals will manage Imperial Hospital, a 375-bedded multispecialty tertiary care hospital based out of Chittagong, Bangladesh, a statement from Apollo Hospitals said.
In line with the mission to bring healthcare of international standards within the reach of every individual, Imperial Hospital and Apollo Hospitals have signed a Brand licensing, Operations and Management Agreement (BOMA), the statement further said.
The Chittagong hospital, branded as Apollo Imperial Hospitals Ltd, will have experienced medical staff, clinicians and administrative staff aimed at providing outstanding services to patients.
Earlier in February, Apollo Hospitals announced a partnership with the Marafon Group to establish a first-of-its-kind tertiary care hospital in Uzbekistan.
The tertiary care hospital, which is to be built in the Fergana region, will primarily focus on specialties such as oncology, organ transplantation, urology, neurosurgery, cardiology, and high-end diagnostics.
The tertiary care hospital was set up at a cost of about ₹1,000 crore (US$128 million) by the Imperial Hospital Group along with direct investment from the World Bank.
Apollo Hospitals shall manage the day-to-day operations and clinical service delivery, utilizing their clinical and managerial capabilities.
Apollo Hospitals team shall also conduct regular medical and quality audits to ensure patient safety and the best medical outcomes for all patients visiting Apollo Imperial Hospital, the statement added.
Dinesh Madhavan, President Group Oncology and International, Apollo Hospitals, said the tertiary care hospital was set up at a cost of about ₹1,000 crore (US$128 million) by the Imperial Hospital Group along with direct investment from the World Bank.
As part of the partnership, Apollo Hospitals will charge a management fee which includes a fixed fee and a variable share of the revenue.
“The option to take a stake is also there in the agreement. If we do well and the current Board members allow us, we can get into financial discussions and participation. However, it is too early to talk about it now,” Madhavan said.
The hospital will commence operations on July 22.
Apollo Hospitals accredited for digital tech in healthcare
Meanwhile, Apollo Hospitals has achieved Stage 6 accreditations for three HIMSS digital maturity models for its digital health capabilities.
The accreditations have been bagged for the Digital Imaging Adoption Model (DIAM), the Outpatient Electronic Medical Record Adoption Model (O-EMRAM), and the Infrastructure Adoption Model (INFRAM).
Apollo Hospitals has now become the second healthcare provider in the world to achieve Stage 6 DIAM, following Nicklaus Children’s Hospital in Florida, USA.
It is also the third organization in the region to attain Stage 6 INFRAM accreditation, following Tu Ora Compass Health in New Zealand and Samsung Medical Center in South Korea.
In March, Apollo Hospitals introduced a mixed reality program called ProHealthDeepX, which uses the Microsoft HoloLens 2 to show how a patient’s risk factors for cardiovascular disease affect their heart.
This came after the launch of its AI-powered Cardiovascular Disease Risk tool last year. Trained using data from over 400,000 Indian patients, the AI tool renders a patient’s risk score, taking into account their various lifestyle attributes and vital signs.
Apollo Hospitals, which operates over 70 private hospitals with more than 12,000 beds across Asia, recognizes the “severe” shortage of healthcare delivery infrastructure worldwide, with the only way to meet this need being the deployment of “effective technology” for healthcare delivery.
According to its press statement, during its DIAM validation, Apollo Hospitals was commended for its use of biomarkers, molecular imaging, and mapping software.
It also showed finesse in using graphs and dashboards to understand and manipulate data.
Simon Lin, HIMSS VP and Executive Director for Asia-Pacific said: “Apollo has continued to show commitment and consistency in advancing their digital health capabilities to ensure that they can leverage the full potential of digital technology to continue driving optimal patient outcomes.”
Apollo has now become the first in the APAC region and second in the world to achieve DIAM Stage 6, he added.
STAGE 6 enables Structured or Coded Data from external sources to be integrated into the Clinical Data Repository, an icon is used to indicate external data is available for clinician teams.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE